The University of Chicago Header Logo

Connection

Ann Marie Mauer to Vascular Endothelial Growth Factor A

Back to Details
This is a "connection" page, showing publications Ann Marie Mauer has written about Vascular Endothelial Growth Factor A.
Ann Marie Mauer
Connection Strength
0.014
Vascular Endothelial Growth Factor A
  1. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.